CELESTON CHRONODOSE

Main information

  • Trade name:
  • CELESTON CHRONODOSE (3+3) mg/ ml suspension for injection
  • Dosage:
  • (3+ 3) mg/ ml
  • Pharmaceutical form:
  • suspension for injection
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • CELESTON CHRONODOSE (3+3) mg/ml suspension for injection
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Betamethasone

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 3677
  • Authorization date:
  • 11-05-2007
  • Last update:
  • 20-02-2018